BIOMAT Database Logo BIOMAT Database Logo

Insolubilization of low density lipoprotein induces cholesterol accumulation in cultured subendothelial cells of human aorta. 1989

A N Orekhov, and V V Tertov, and D N Mukhin, and V E Koteliansky, and M A Glukhova, and M G Frid, and G K Sukhova, and K A Khashimov, and V N Smirnov
Institute of Experimental Cardiology, Cardiology Research Center of the U.S.S.R., Academy of Medical Sciences, Moscow.

Primary cultures of typical and modified smooth muscle cells isolated from the intima of human aorta were used to study the mechanism whereby low density lipoprotein (LDL) induces accumulation of intracellular cholesterol. Incubation of intimal cells with native LDL obtained from human plasma did not lead to deposition of total cholesterol. LDL added to the cultures simultaneously with hyaluronic acid, heparin, chondroitin sulfate, fibronectin, and mouse monoclonal antibody against LDL also failed to alter the cellular cholesterol. On the other hand, 24-h incubation of the cells with LDL in the presence of dextran sulfate, gelatin, particles of aortic elastin, particles of collagenase-resistant aortic matrix, goat polyclonal antibodies against LDL or latex beads caused a significant (1.5-7-fold) increase in total cholesterol. The compounds which stimulated cholesterol deposition are able to form precipitating complexes with LDL. On the contrary, the agents which failed to induce cholesterol accumulation were unable to insolubilize LDL. A direct correlation (r = 0.927) was found between the cholesterol content of the insoluble complex and the increment of cholesterol in the cultured cells. To find out whether LDL plays a specific role in the deposition of intracellular cholesterol, very low density lipoproteins and high density lipoproteins were used. These lipoproteins stimulated the accumulation of intracellular cholesterol in the presence of agents capable of forming insoluble associates with them. Our data suggest that insolubilization of lipoproteins is a key event in the LDL-mediated accumulation of intracellular cholesterol induced by various agents.

UI MeSH Term Description Entries
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005353 Fibronectins Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins. Cold-Insoluble Globulins,LETS Proteins,Fibronectin,Opsonic Glycoprotein,Opsonic alpha(2)SB Glycoprotein,alpha 2-Surface Binding Glycoprotein,Cold Insoluble Globulins,Globulins, Cold-Insoluble,Glycoprotein, Opsonic,Proteins, LETS,alpha 2 Surface Binding Glycoprotein
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A N Orekhov, and V V Tertov, and D N Mukhin, and V E Koteliansky, and M A Glukhova, and M G Frid, and G K Sukhova, and K A Khashimov, and V N Smirnov
Low-density lipoprotein uptake and cholesterol accumulation by cultured renal cells.
December 1991, Journal of the American Society of Nephrology : JASN,
A N Orekhov, and V V Tertov, and D N Mukhin, and V E Koteliansky, and M A Glukhova, and M G Frid, and G K Sukhova, and K A Khashimov, and V N Smirnov
Low density lipoprotein modification by cholesterol oxidase induces enhanced uptake and cholesterol accumulation in cells.
January 1992, The Journal of biological chemistry,
A N Orekhov, and V V Tertov, and D N Mukhin, and V E Koteliansky, and M A Glukhova, and M G Frid, and G K Sukhova, and K A Khashimov, and V N Smirnov
Platelet-modified low density lipoprotein induces macrophage cholesterol accumulation and platelet activation.
January 1989, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
A N Orekhov, and V V Tertov, and D N Mukhin, and V E Koteliansky, and M A Glukhova, and M G Frid, and G K Sukhova, and K A Khashimov, and V N Smirnov
Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells.
October 1988, The Journal of biological chemistry,
A N Orekhov, and V V Tertov, and D N Mukhin, and V E Koteliansky, and M A Glukhova, and M G Frid, and G K Sukhova, and K A Khashimov, and V N Smirnov
Nifedipine inhibits accumulation of low density lipoprotein and cholesterol in the aorta of normocholesterolaemic rabbits.
January 1994, Drugs,
A N Orekhov, and V V Tertov, and D N Mukhin, and V E Koteliansky, and M A Glukhova, and M G Frid, and G K Sukhova, and K A Khashimov, and V N Smirnov
Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells.
March 1991, The American journal of pathology,
A N Orekhov, and V V Tertov, and D N Mukhin, and V E Koteliansky, and M A Glukhova, and M G Frid, and G K Sukhova, and K A Khashimov, and V N Smirnov
The low-density lipoprotein pathway of cultured Leydig tumor cells. Utilization of low-density lipoprotein-derived cholesterol for steroidogenesis.
November 1983, Biochimica et biophysica acta,
A N Orekhov, and V V Tertov, and D N Mukhin, and V E Koteliansky, and M A Glukhova, and M G Frid, and G K Sukhova, and K A Khashimov, and V N Smirnov
Uptake of [3H]cholesterol from low density lipoprotein by cultured human fibroblasts.
May 1982, Biochimica et biophysica acta,
A N Orekhov, and V V Tertov, and D N Mukhin, and V E Koteliansky, and M A Glukhova, and M G Frid, and G K Sukhova, and K A Khashimov, and V N Smirnov
[Effect of eicosanoids on the accumulation of cholesterol and the proliferation of subendothelial cells in the human aorta].
January 1988, Biulleten' eksperimental'noi biologii i meditsiny,
A N Orekhov, and V V Tertov, and D N Mukhin, and V E Koteliansky, and M A Glukhova, and M G Frid, and G K Sukhova, and K A Khashimov, and V N Smirnov
Studies on lipoprotein and adrenal steroidogenesis: I. Roles of low density lipoprotein- and high density lipoprotein-cholesterol in steroid production in cultured human adrenocortical cells.
October 1987, Endocrinologia japonica,
Copied contents to your clipboard!